chr11-66526649-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_024649.5(BBS1):c.1181G>A(p.Gly394Asp) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000154 in 1,614,216 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_024649.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BBS1 | NM_024649.5 | c.1181G>A | p.Gly394Asp | missense_variant, splice_region_variant | 13/17 | ENST00000318312.12 | NP_078925.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BBS1 | ENST00000318312.12 | c.1181G>A | p.Gly394Asp | missense_variant, splice_region_variant | 13/17 | 1 | NM_024649.5 | ENSP00000317469.7 | ||
ENSG00000256349 | ENST00000419755.3 | c.1292G>A | p.Gly431Asp | missense_variant, splice_region_variant | 13/17 | 2 | ENSP00000398526.3 |
Frequencies
GnomAD3 genomes AF: 0.000887 AC: 135AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000199 AC: 50AN: 251458Hom.: 0 AF XY: 0.000169 AC XY: 23AN XY: 135914
GnomAD4 exome AF: 0.0000773 AC: 113AN: 1461892Hom.: 0 Cov.: 32 AF XY: 0.0000688 AC XY: 50AN XY: 727246
GnomAD4 genome AF: 0.000886 AC: 135AN: 152324Hom.: 0 Cov.: 32 AF XY: 0.000846 AC XY: 63AN XY: 74482
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 07, 2024 | Reported along with a second variant in the BBS1 gene in a patient with congenital heart disease in the published literature; however, evidence in support of pathogenicity for this variant was not provided in the report (PMID: 28991257); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34426522, 28991257) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 15, 2016 | - - |
Bardet-Biedl syndrome 1 Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Jun 30, 2021 | - - |
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Apr 14, 2020 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Dec 18, 2016 | - - |
BBS1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 17, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Bardet-Biedl syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at